Clean Energy and Healthcare Lead Pre-Market Gains Amidst Tech Sector Challenges

📈 Today's Key Themes

Pre-market sentiment is mixed across sectors, with clean energy and healthcare showing notable strength while the tech sector faces headwinds. ITM Power's significant revenue guidance increase and AOTI's NHS framework agreement highlight positive developments in renewable energy and cost-effective healthcare solutions. However, challenges persist in the tech and biotech sectors, as evidenced by Celebrus Technologies' revenue decline and Arecor Therapeutics' widening losses. This diverse landscape suggests a potentially volatile opening for the London Stock Exchange, with investors likely to scrutinize sector-specific performance closely.

💡 Company Updates

Annual Results and Trading Updates

ITM Power (#ITM) has raised its full-year revenue guidance for FY25 by an impressive 30% to £25.5m - £26.5m. The industrial machinery company also expects to be net cash generative in the second half of FY25, with cash at the end of the year projected to be between £204m and £205m. This positive update, coupled with unchanged adjusted EBITDA loss guidance, suggests ITM Power is well-positioned to deliver on its growth plans. Sentiment: Very Good.

Celebrus Technologies (#CLBS) faces challenges as it anticipates full-year revenues for FY2025 to be behind expectations at approximately $38.6 million, down from $40.9 million in FY24. Despite this, adjusted profit before tax is expected to be ahead at around $8.7 million. The company cites slowing customer decision-making and uncertainty around future revenues as key concerns. Sentiment: Bad.

Arecor Therapeutics (#AREC) reported increased losses in its 2024 final results, with loss after tax rising to £10.2 million from £8.6 million in 2023. Total revenue saw a modest increase to £5.1 million. The company's cash position decreased significantly to £3.3 million from £6.8 million in 2023. Despite these financial challenges, Arecor highlighted positive advancements in its diabetes portfolio, particularly with AT278. Sentiment: Bad.

🎯 Leading Developments

AOTI (#AOTI) has secured a significant win with the inclusion of its TWO2® therapy in the NHS supply chain framework agreement for Advanced Wound Care 2025. This development is expected to provide easier access for patients in England and deliver substantial cost savings for the healthcare system. A health economic study suggests that TWO2® therapy could significantly lower overall diabetic foot care costs for the NHS in England, addressing a condition that currently accounts for almost 1% of the entire annual NHS budget. This contract win provides AOTI with a clear path to revenue growth and improved profitability. Sentiment: Very Good. Read more

Helium One Global (#HE1) has received approval to construct a helium and CO2 processing plant for its Galactica-Pegasus project in Colorado. This marks a critical milestone in the project's development and demonstrates strong support from local authorities and stakeholders. The permit approval positions Helium One well to advance the project to construction and operational phases, potentially boosting its market position in the helium and CO2 sectors. Sentiment: Very Good. Read more

Shield Therapeutics (#STX) has secured an exclusive licence agreement with VITAL-NET, Inc. for its iron deficiency treatment ACCRUFeR® in Japan. The deal includes an initial payment, regulatory and sales milestones, and double-digit royalties. This agreement expands the global footprint of ACCRUFeR® and could generate meaningful long-term revenue for Shield Therapeutics. Sentiment: Good. Read more

Kavango Resources (#KAV) has secured a US$5 million convertible loan note facility from a consortium of Zimbabwe pension funds. The interest-free loan can be drawn down in three tranches over the next 12 months and will be used for mine development and import of mining equipment in Zimbabwe. This financing provides Kavango with additional funding to support its operations in a key growth market. Sentiment: Good. Read more

Mkango Resources (#MKA) has appointed lead engineers PegasusTSI and BBA to complete the EPCM services for its HyProMag USA rare earth magnet recycling project. The project has strong financial potential, with a NPV7% of US$262 million based on current market prices. This development represents a significant strategic move for Mkango in the US rare earth magnet market. Sentiment: Good. Read more

📅 Week Ahead

23 April 2025: Greatland Gold (#GGP) UK Court hearing for corporate reorganization and ASX listing
23 April 2025: AB Dynamics (#ABDP) Interim results for the six months ended 28 February 2025
23 April 2025: Gulf Keystone Petroleum (#GKP) Interim dividend payment date
23 April 2025: Foxtons Group (#FOXT) Q1 2025 Trading Update
24 April 2025: Unilever (#ULVR) Q1 2025 trading statement
24 April 2025: Compagnie de Saint-Gobain (#COD) Sales for the first quarter of 2025
24 April 2025: ASOS (#ASC) Announcement of H1 FY25 results
25 April 2025: WPP (#WPP) Q1 2025 Trading Update
25 April 2025: ME Group International (#MEGP) Annual General Meeting

View full calendar

Market Summary